Back to Search
Start Over
Chrysin inhibits tumor promoter-induced MMP-9 expression by blocking AP-1 via suppression of ERK and JNK pathways in gastric cancer cells.
- Source :
-
PloS one [PLoS One] 2015 Apr 15; Vol. 10 (4), pp. e0124007. Date of Electronic Publication: 2015 Apr 15 (Print Publication: 2015). - Publication Year :
- 2015
-
Abstract
- Cell invasion is a crucial mechanism of cancer metastasis and malignancy. Matrix metalloproteinase-9 (MMP-9) is an important proteolytic enzyme involved in the cancer cell invasion process. High expression levels of MMP-9 in gastric cancer positively correlate with tumor aggressiveness and have a significant negative correlation with patients' survival times. Recently, mechanisms suppressing MMP-9 by phytochemicals have become increasingly investigated. Chrysin, a naturally occurring chemical in plants, has been reported to suppress tumor metastasis. However, the effects of chrysin on MMP-9 expression in gastric cancer have not been well studied. In the present study, we tested the effects of chrysin on MMP-9 expression in gastric cancer cells, and determined its underlying mechanism. We examined the effects of chrysin on MMP-9 expression and activity via RT-PCR, zymography, promoter study, and western blotting in human gastric cancer AGS cells. Chrysin inhibited phorbol-12-myristate 13-acetate (PMA)-induced MMP-9 expression in a dose-dependent manner. Using AP-1 decoy oligodeoxynucleotides, we confirmed that AP-1 was the crucial transcriptional factor for MMP-9 expression. Chrysin blocked AP-1 via suppression of the phosphorylation of c-Jun and c-Fos through blocking the JNK1/2 and ERK1/2 pathways. Furthermore, AGS cells pretreated with PMA showed markedly enhanced invasiveness, which was partially abrogated by chrysin and MMP-9 antibody. Our results suggest that chrysin may exert at least part of its anticancer effect by controlling MMP-9 expression through suppression of AP-1 activity via a block of the JNK1/2 and ERK1/2 signaling pathways in gastric cancer AGS cells.
- Subjects :
- Antibodies pharmacology
Cell Line, Tumor
Cell Movement drug effects
Dose-Response Relationship, Drug
Epithelial Cells metabolism
Epithelial Cells pathology
Gastric Mucosa metabolism
Humans
Matrix Metalloproteinase 9 metabolism
Mitogen-Activated Protein Kinase 1 antagonists & inhibitors
Mitogen-Activated Protein Kinase 1 genetics
Mitogen-Activated Protein Kinase 1 metabolism
Mitogen-Activated Protein Kinase 3 antagonists & inhibitors
Mitogen-Activated Protein Kinase 3 genetics
Mitogen-Activated Protein Kinase 3 metabolism
Mitogen-Activated Protein Kinase 8 antagonists & inhibitors
Mitogen-Activated Protein Kinase 8 genetics
Mitogen-Activated Protein Kinase 8 metabolism
Mitogen-Activated Protein Kinase 9 antagonists & inhibitors
Mitogen-Activated Protein Kinase 9 genetics
Mitogen-Activated Protein Kinase 9 metabolism
Oligodeoxyribonucleotides genetics
Oligodeoxyribonucleotides metabolism
Phosphorylation
Proto-Oncogene Proteins c-fos genetics
Proto-Oncogene Proteins c-fos metabolism
Signal Transduction
Stomach drug effects
Stomach pathology
Tetradecanoylphorbol Acetate antagonists & inhibitors
Tetradecanoylphorbol Acetate pharmacology
Transcription Factor AP-1 antagonists & inhibitors
Transcription Factor AP-1 metabolism
Antineoplastic Agents, Phytogenic pharmacology
Epithelial Cells drug effects
Flavonoids pharmacology
Gene Expression Regulation, Neoplastic
Matrix Metalloproteinase 9 genetics
Transcription Factor AP-1 genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1932-6203
- Volume :
- 10
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- PloS one
- Publication Type :
- Academic Journal
- Accession number :
- 25875631
- Full Text :
- https://doi.org/10.1371/journal.pone.0124007